Symmetry Medical to Report Second Quarter 2008 Financial Results on August 6, 2008

WARSAW, Ind., July 29 Symmetry Medical Inc.(NYSE: SMA), a leading independent provider of products to the globalorthopedic device industry and other medical markets, announced today that itwill release second quarter financial results for the period ending June 28,2008 before the market opens on Wednesday, August 6, 2008. Symmetry Medicalwill host an accompanying conference call at 8:00 a.m. ET on Wednesday, August6.

A live Web cast of the conference call will be available online from theinvestor relations page of the Company's corporate website athttp://www.symmetrymedical.com. The dial-in numbers are (866) 831-6270 fordomestic callers and (617) 213-8858 for international. The reservation numberfor both is 67440328. After the live Web cast, the call will remain availableon Symmetry Medical's Web site through November 6, 2008. In addition, atelephonic replay of the call will be available until August 20, 2008. Thereplay numbers are (888) 286-8010 for domestic callers and (617) 801-6888 forinternational callers. Please use reservation code 67505293.

About Symmetry Medical Inc.

Symmetry Medical Inc. is a leading independent provider of implants andrelated instruments and cases to the orthopedic device industry. The Companyalso designs, develops and produces these products for companies in othersegments of the medical device market, including arthroscopy, dental,laparoscopy, osteobiologic and endoscopy sectors and provides limitedspecialized products and services to non-healthcare markets, such as theaerospace market.Investors/Media: Contact: The Ruth Group Symmetry Medical Inc. Nick Laudico/Jason Rando Fred L. Hite (646) 536-7030/7025 Senior Vice President [email protected] Chief Financial Officer [email protected] (574) 371-2218

SOURCE Symmetry Medical Inc.

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...